Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed (MYNZ) Net Income towards Common Stockholders (2022 - 2023)

Historic Net Income towards Common Stockholders for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$5.2 million.

  • Mainz Biomed's Net Income towards Common Stockholders rose 3670.12% to -$5.2 million in Q4 2023 from the same period last year, while for Jun 2025 it was -$5.2 million, marking a year-over-year increase of 7373.51%. This contributed to the annual value of -$21.7 million for FY2024, which is 1781.71% up from last year.
  • Per Mainz Biomed's latest filing, its Net Income towards Common Stockholders stood at -$5.2 million for Q4 2023, which was up 3670.12% from -$6.3 million recorded in Q3 2023.
  • Mainz Biomed's Net Income towards Common Stockholders' 5-year high stood at -$5.2 million during Q4 2023, with a 5-year trough of -$8.3 million in Q2 2023.